1. Summary Information
|
|
|
Country |
|
|
Company Name |
BIO-MED HEALTH
CARE PRODUCTS PRIVATE LIMITED |
Principal Name 1 |
Mrs. Nirmal Kanta Arora |
|
Status |
Satisfactory |
Principal Name 2 |
Mr. Deepak Chandra Arora |
|
|
|
Registration # |
05-034806 |
|
Street Address |
30, DLF Industrial Estate-I, |
||
|
Established Date |
09.01.2002 |
SIC Code |
-- |
|
Telephone# |
91-129-4096900 |
Business Style 1 |
Manufacturer |
|
Fax # |
91-129-2259898 |
Business Style 2 |
Exporter |
|
Homepage |
Product Name 1 |
Catheters |
|
|
# of employees |
Not Available |
Product Name 2 |
Medical Stop Cock |
|
Paid up capital |
Rs.36,380,000/- |
Product Name 3 |
-- |
|
Shareholders |
Directors and their Relatives – 100% |
Banking |
Punjab National Bank |
|
Public Limited Corp. |
NO |
Business Period |
9 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
Ba (45) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
|
|
|
|
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2010 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
122,548,000 |
Current Liabilities |
75,462,000 |
|
Inventories |
31,437,000 |
Long-term Liabilities |
144,152,000
|
|
Fixed Assets |
165,096,000 |
Other Liabilities |
12,056,000 |
|
Deferred Assets |
0,000 |
Total Liabilities |
231,670,000 |
|
Invest& other Assets |
492,000 |
Retained Earnings |
51,523,000 |
|
|
|
Net Worth |
87,903,000 |
|
Total Assets |
319,573,000 |
Total Liab. & Equity |
319,573,000 |
|
Total Assets (Previous Year) |
247,387,000 |
|
|
|
P/L Statement as of |
31.03.2010 |
(Unit: Indian Rs.) |
|
|
Sales |
403,763,000 |
Net Profit |
18,211,000 |
|
Sales(Previous yr) |
358,874,000 |
Net Profit(Prev.yr) |
9,115,000 |
MIRA
INFORM REPORT
|
Report Date : |
17.10.2011 |
IDENTIFICATION DETAILS
|
Name : |
BIO-MED HEALTH CARE PRODUCTS PRIVATE LIMITED (w.e.f. 30.07.2002) |
|
|
|
|
Formerly Known
As : |
BIO-MED HEALTH CARE PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
30, DLF Industrial Estate-I, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2010 |
|
|
|
|
Date of
Incorporation : |
09.01.2002 |
|
|
|
|
Com. Reg. No.: |
05-034806 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.36.380 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U33112HR2002PTC034806 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and Exporter of medical and surgical supplies like I.V.
cannula, medical syringes, medical stop cock, extension tube and blood
transfusion sets. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 352000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track. Trade relations
are reported as fair. Business is active. Payments are reported to be usually
correct and as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office / Corporate Office / Factory 1 : |
30, DLF Industrial Estate-I, |
|
Tel. No.: |
91-129-4096900 / 2250750 |
|
Fax No.: |
91-129-2259898 / 4096818 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory 2 : |
Plot No.62-65, Sector 6 A, SIDCUL, Haridwar – 249 403, |
DIRECTORS
As on 30.09.2010
|
Name : |
Mr. Deepak Chandra Arora |
|
Designation : |
Director |
|
Address : |
House No-692, Sector-15, |
|
Date of Birth/Age : |
09.01.1976 |
|
Date of Appointment : |
09.01.2002 |
|
DIN No.: |
00906766 |
|
|
|
|
Name : |
Mrs. Nirmal Kanta Arora |
|
Designation : |
Director |
|
Address : |
House No-692, Sector-15, |
|
Date of Birth/Age : |
20.01.1955 |
|
Date of Appointment : |
01.06.2002 |
|
DIN No.: |
01483418 |
|
|
|
|
Name : |
Mr. Jagdish Chand Arora |
|
Designation : |
Director |
|
Address : |
House No-692, Sector-15, |
|
Date of Birth/Age : |
05.09.1950 |
|
Date of Appointment : |
09.01.2002 |
|
DIN No.: |
01809809 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2010
|
Names of Shareholders |
|
No. of Shares |
|
Jagdish Chand Arora |
|
1695000 |
|
Deepak Chandra Arora |
|
1030000 |
|
Nirmal Kanta Arora |
|
761000 |
|
Poonam Arora |
|
31000 |
|
Rachana Arora |
|
61000 |
|
Charu Arora |
|
60000 |
|
Total |
|
3638000 |
Equity Share Break up (Percentage of Total Equity)
As on 30.09.2010
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and exporter of medical and surgical supplies, I.V.
cannula, medical syringes, medical stop cock, extension tube and blood
transfusion sets. |
|
|
|
|
Products / Services : |
INFUSION THERAPY
CATHETERS
|
|
|
|
|
Exports : |
|
|
Countries : |
|
GENERAL INFORMATION
|
No. of Employees : |
Not available |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
Note : secured by way of mortgage of Building, hypothecation of assets
and Fully guaranteed by the directors
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Financial Institution : |
|
|
|
|
|
Auditors : |
|
|
Name : |
KSMC and Associates Chartered Accountants |
|
Address : |
G-5, Vikas |
|
PAN.: |
AADPA1082D |
CAPITAL STRUCTURE
As on 31.03.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
5000000 |
Equity Shares |
Rs.10/- each |
Rs.50.000 millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
3238000 |
Equity Shares |
Rs.10/- each |
Rs.32.380
Millions |
|
|
Add : Issued(400000 @ Rs.10/-) |
|
Rs.4.000
Millions |
|
|
Total |
|
Rs.36.380 Millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
36.380 |
32.380 |
32.380 |
|
|
2] Share Application Money |
0.000 |
0.000 |
4.000 |
|
|
3] Reserves & Surplus |
51.523 |
33.312 |
24.197 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
87.903 |
65.692 |
60.577 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
121.379 |
80.383 |
96.889 |
|
|
2] Unsecured Loans |
22.773 |
25.477 |
21.845 |
|
|
TOTAL BORROWING |
144.152 |
105.860 |
118.734 |
|
|
DEFERRED TAX LIABILITIES |
3.846 |
3.493 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
235.901 |
175.045 |
179.311 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
165.096 |
135.567 |
134.124 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.492 |
0.492 |
0.492 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
1.266 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
31.437
|
22.351 |
24.039 |
|
|
Sundry Debtors |
78.209
|
56.608 |
44.504 |
|
|
Cash & Bank Balances |
11.766
|
4.968 |
8.178 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
32.573
|
31.286 |
16.462 |
|
Total
Current Assets |
153.985
|
115.213 |
93.183 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
51.753
|
50.347 |
40.050 |
|
|
Other Current Liabilities |
23.709
|
21.995 |
8.896 |
|
|
Provisions |
8.210
|
3.885 |
0.808 |
|
Total
Current Liabilities |
83.672
|
76.227 |
49.754 |
|
|
Net Current Assets |
70.313
|
38.986 |
43.429 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
235.901 |
175.045 |
179.311 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
403.763 |
358.874 |
269.166 |
|
|
|
Other Income |
8.956 |
7.670 |
(0.039) |
|
|
|
TOTAL |
412.719 |
366.544 |
269.127 |
|
|
|
|
|
|
|
|
Less |
|
|
|
|
|
|
|
Office Expenses |
|
|
|
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL |
385.945 (Including
Financial Charges and Depreciation) |
348.786 (Including
Financial Charges and Depreciation) |
265.572 (Including
Financial Charges and Depreciation) |
|
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
|
|
|
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
|
|
|
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
26.774 |
17.758 |
3.555 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
8.563 |
8.643 |
0.808 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX |
18.211 |
9.115 |
2.747 |
|
|
|
|
|
|
|
|
|
|
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
33.312 |
24.197 |
36.315 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
51.523 |
33.312 |
39.062 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export at FOB Value |
276.496 |
284.262 |
228.063 |
|
|
|
Other Earnings |
0.000 |
1.399 |
0.000 |
|
|
TOTAL EARNINGS |
276.496 |
285.661 |
228.063 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
5.01 |
2.81 |
0.85 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
4.41
|
2.49 |
1.02 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
6.63
|
4.95 |
1.32 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
8.39
|
7.08 |
1.56 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.30
|
0.27 |
0.06 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
2.59
|
2.77 |
2.78 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.84
|
1.51 |
1.87 |
LOCAL AGENCY FURTHER INFORMATION
CONTINGENT
LIABILITY
(Rs. In Millions)
|
Particulars |
31.03.2010 |
31.03.2009 |
|
L/C Issued By Bank |
54.556 |
35.239 |
|
Bank Guarantee |
2.922 |
2.761 |
FORM 8
|
Corporate
identity number of the company |
U33112HR2002PTC034806 |
|
Name of the
company |
BIO-MED HEALTH
CARE PRODUCTS PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
30, DLF
Industrial Estate-I, E-mail : vkn@acropolisgroup.in |
|
This form is for |
Modification of charge |
|
Charge identification
(ID) number of the charge to be modified |
10274817 |
|
Type of charge |
Immovable property Book debts Movable property (not being pledge) Others (FDR of Rs.2.267 Millions lien marked to
SIDBI.) |
|
Particular of
charge holder |
Small Industries
Development Bank Of E-mail : singhsp@sidbi.in
|
|
Nature of
instrument creating charge |
Deed of
Hypothecation dated 08.08.2011. |
|
Date of
instrument Creating the charge |
08.08.2011 |
|
Amount secured by
the charge |
Rs.5.000 Millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Rate of interest @11.50% p.a. with
monthly rests on the principal amount of loan outstanding from time to time. Terms of repayment The loan to be
repaid in 54 monthly installments comprising first 53 installments of
Rs.0.093 Million each followed by last installment of Rs.0.071 Million commencing
after 6 months from the date of first disbursement. Extent and operation of the charge The term loan of
Rs.5.000 Millions is secured by way of charges on the assets of the company
as described in 15(i) to 15(x). |
|
Short particulars
of the property or asset(s) charged (including complete address and location
of the property) |
First charge by
way of hypothecation over movable items of plant, machinery and other
equipment acquired/ to be acquired under this scheme/ project and placed/ to
be placed at Plot No.30, DLF Industrial Estate I, Faridabad and Plots 62 to
65, Sector- 6A, SIDCUL, Haridwar, Uttrakhand. Extension of first charge by
way of hypothecation over existing movable items of plant machinery and other
equipment acquired under all the previous schemes/ projects and kept at Plot
No.30, DLF Industrial Estate I, Extension of
charge/ lien on duly discharged FDR of Rs.2.267 Millions with accrued
interests already available with SIDBI. Extension of
second charge on all the fixed assets, including movables, immovable, current
assets of the company, first charge being held by Axis Bank for the limits
granted to the company. Extension of
Second charge on the immovable properties of the company located at (a) Plot No.30,
DLF Industrial Estate, Phase I, (b) Plot No.62 to
65, Sector 6A, Integrated Industrial Estate (IIE), SIDCUL, BHEL, Ranipur,
Village Salempur Mehdood, District. Haridwar, admeasuring about 4000 sq.
mtrs. (c) Industrial
land measuring 16 Kanals 5 Marlas, in Khewat/Khatauni No.598/687, Mustail
(Rectangle) No.122, bearing Khasra No.122, Kila No.9/2(7-7), 10/1/1(0-9),
12/1(6-7), 8/3 (1-2) 26/2(1-0)
situated in village Prithla, Tehsil Palwal, District. |
|
Particulars of
the present modification |
The term loan of
Rs.5.000 Millions granted to the company is further secured by extension of
second charge on all the fixed assets, including movables, immovable, current
assets of the company, first charge being held by Axis Bank for the limits
granted to the company. Other terms and conditions remain the same. |
FIXED ASSESTS
·
A/C and Cooler
·
Building
·
Computer
·
Electrical Installation
·
Fire Fighting Equipments
·
Furniture and Fixtures
·
Lab Equipments
·
Plant and Machinery
·
Car
·
Vehicles (other than Car)
·
Land
WEBSITE DETAILS
COMPANY PROFILE
Subject was founded on the of January 2002,
with a focused vision of applying Advanced Technologies to the development of
highest quality products at the most affordable prices in the field of
Healthcare Disposables. Subject boasts of an impressive state-of-the-art
facility in the industrial town of
- Controlled Molding area
- State-of-the-art Clean Room of Class 10,000
- ETO Gas Sterilization Plant and all other modern amenities and
facilities required for manufacturing and testing of Medical Devices
The company has developed research driven
dedicated team of professionals having hardcore experience in applying advanced
technologies to the development of superior high qualitytools for the Medical
profession and the end user. In its drive to become the leading manufacturer in
the field of Health Care Disposables, the company has developed quality and
product system as per ISO 9001-2000 and EN 46001 Standards and its Products are
all CE marked.
The Company follows the Principles of
“SIX-SIGMA” to optimize all the departments involved in the infrastructure. The
products manufactured undergo rigorous physical, chemical and Biological
inspections, to meet out the best of standards in the industry. They at Subject
aim at absolute customer satisfaction and optimum product quality assurance and
prompt service.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.07 |
|
|
1 |
Rs.77.42 |
|
Euro |
1 |
Rs.67.73 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.